4
Changes in Ownership
Bioventus Inc. Filed Acc 0000899243-23-008792
Chief Executive Officer sold 9,811 shares at $1.39 ($13,625)
- Chief Executive Officer acquired 28,721 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Reali Kenneth Michael · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-03-14 | Exercise or conversion : show line 1 in the form | +28,721 | 39,896 | D | ||
| 2023-03-15 | Sale : show line 2 in the form | −9,811 | $1.39 | $13,625 | 30,085 | D |
| Open-market sales · 9,811 sh · avg $1.39 · $13,625 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-14 | Grant or award : show line 3 in the form Restricted Stock Units | +114,882 | 114,882 | D |
| 2023-03-14 | Exercise or conversion : show line 4 in the form Restricted Stock Units | −28,721 | 86,161 | D |
Loading xslF345X03/doc4.xml…